Trademark: 85300372
Word
MYDOCETAXEL BECAUSE NO TWO PATIENTS ARE ALIKE
Status Date
Friday, March 24, 2023
Registration Number
4207024
Registration Date
Tuesday, September 11, 2012
Filing Date
Wednesday, April 20, 2011
Published for Opposition
Tuesday, October 18, 2011
Cancellation Date
Friday, March 24, 2023
5 Test kits comprised of medical diagnostic grade reagents for determining the concentration of drugs in the blood of cancer patients
The mark consists of the literal element "MYDOCETAXEL" positioned above the literal element "BECAUSE NO TWO PATIENTS ARE ALIKE". The letter "Y" is highly stylized in the form of a human figure with outstretched arms.
MY DOCETAXEL BECAUSE NO TWO PATIENTS ARE ALIKE
Color is not claimed as a feature of the mark.
"DOCETAXEL"
Mar 24, 2023
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Oct 24, 2017
Notice Of Acceptance Of Sec. 8 - Mailed
Oct 24, 2017
Registered - Sec. 8 (6-Yr) Accepted
Oct 20, 2017
Case Assigned To Post Registration Paralegal
Sep 22, 2017
Teas Section 8 Received
Sep 22, 2017
Teas Change Of Correspondence Received
Sep 11, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 11, 2012
Registered-Principal Register
Aug 7, 2012
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 6, 2012
Law Office Registration Review Completed
Jul 31, 2012
Assigned To Lie
Jul 17, 2012
Allowed Principal Register - Sou Accepted
Jun 25, 2012
Statement Of Use Processing Complete
May 29, 2012
Use Amendment Filed
Jun 25, 2012
Case Assigned To Intent To Use Paralegal
May 29, 2012
Teas Statement Of Use Received
Dec 13, 2011
Noa E-Mailed - Sou Required From Applicant
Nov 30, 2011
Assigned To Examiner
Oct 18, 2011
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2011
Published For Opposition
Aug 22, 2011
Withdrawn From Pub - Og Review Query
Aug 3, 2011
Approved For Pub - Principal Register
Jul 27, 2011
Assigned To Examiner
Apr 26, 2011
Notice Of Design Search Code Mailed
Apr 25, 2011
New Application Office Supplied Data Entered
Apr 23, 2011
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
